Skip to main content

GOLDMAN SACHS GROUP INC

Position in EBS — Emergent BioSolutions Inc.

CIK 886982 NEW YORK, NY

Position in EBS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$8,676,827
+$1,940,880 QoQ
Shares Held
1,035,421
+27.6% QoQ
Ownership
2.02%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 194 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EBS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $1,964,785,401 across 53 Drug Manufacturers - Specialty & Generic names. EBS ranks #29 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in EBS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,676,827 1,035,421
2026-03-31 $6,735,947 811,560
2025-12-31 $9,147,635 740,100
2025-09-30 $5,477,016 620,977
2025-06-30 $3,696,519 579,392
2025-03-31 $5,300,582 1,090,655
2024-12-31 $9,264,327 969,072
2024-09-30 $3,739,530 447,848
2024-06-30 $4,166,808 610,969
2024-03-31 $741,170 292,953
2023-12-31 $1,804,528 751,887
2023-09-30 $2,239,191 658,586
2023-06-30 $4,927,807 670,450
2023-03-31 $9,329,645 900,545
2022-12-31 $9,207,606 779,645
2022-09-30 $9,628,574 458,722
2022-06-30 $14,226,717 458,335
2022-03-31 $14,342,956 349,317
2021-12-31 $13,722,826 315,685
2021-09-30 $35,430,583 707,621
2021-06-30 $41,264,747 655,100
2021-03-31 $44,445,448 478,371
2020-12-31 $80,695,103 900,615
2020-09-30 $66,470,225 643,281
2020-06-30 $60,355,752 763,224
2020-03-31 $55,889,287 965,940